ZUNALIN COUGH

This brand name is authorized in Nigeria.

Active ingredients

The drug ZUNALIN COUGH contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Ephedrine UNII `NLJ6390P1Z` - EPHEDRINE HYDROCHLORIDE
	Ephedrine is a sympathomimetic amine acting directly on the alpha and beta receptors and indirectly by increasing the release of noradrenaline by the sympathetic nerve endings. As with any sympathomimetic agent, ephedrine stimulates the central nervous system, the cardiovascular system, the respiratory system, and the sphincters of the digestive and urinary systems.
	Read more about Ephedrine
`2`	Chlorphenamine UNII `V1Q0O9OJ9Z` - CHLORPHENIRAMINE MALEATE
	Chlorphenamine is a potent antihistamine (H₁-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H₁-receptor sites on tissues. Chlorphenamine also has anticholinergic activity.
	Read more about Chlorphenamine
`3`	Ammonium chloride UNII `01Q9PC255D` - AMMONIUM CHLORIDE
	Read more about Ammonium chloride
`4`	Sodium citrate UNII `1Q73Q2JULR` - SODIUM CITRATE, UNSPECIFIED FORM
	Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section.
	Read more about Sodium citrate
`5`	Menthol UNII `L7T10EIP3A` - MENTHOL, UNSPECIFIED FORM
	Read more about Menthol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0025	Syrup	Zunalin Cough Linctus SYRUP 2 mg	Zunalin Cough Linctus A11-0025 Chlorpheniramine Maleate+Ammonium Chloride+Sodium Citrate+Ephedrine Hydrochloride+Menthol Expectorant Oral 2 mg Linctus Over The Counter (Otc) Zunamediks Pharm.Ltd Zunamediks Pharma Limited Nigeria 2020-12-21 2025-12-20	21/12/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R05CA10	Combinations	R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CA Expectorants
Discover more medicines within R05CA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0025

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.